Market Cap 4.59B
Revenue (ttm) 3.13B
Net Income (ttm) 359.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.48%
Debt to Equity Ratio 0.59
Volume 200
Avg Vol 1,540
Day's Range N/A - N/A
Shares Out 221.89M
Stochastic %K 35%
Beta 0.59
Analysts Sell
Price Target N/A

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and speci...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 44 20 7399 2760
Address:
1 New Burlington Place, London, United Kingdom
Latest News on HKMPF
No data available.